Artis BioSolutions

Artis BioSolutions is a growth equity company that provides capital and operational expertise to accelerate discovery, development, and commercial production of genetic medicines and biologics. The firm supports programs from Phase 1 to commercial readiness and focuses on scaling manufacturing, technology transfer, and analytical development for modalities including cell & gene, mRNA, peptide, and oligonucleotide therapies.